Clinical experience of reoperative right ventricular outflow tract reconstruction with valved conduits: risk factors for conduit failure in long-term follow-up.
Allograft
Conduit failure
Reoperation
Right ventricular outflow tract
Valved conduit
Xenograft
Journal
Cell and tissue banking
ISSN: 1573-6814
Titre abrégé: Cell Tissue Bank
Pays: Netherlands
ID NLM: 100965121
Informations de publication
Date de publication:
21 Apr 2023
21 Apr 2023
Historique:
received:
02
07
2022
accepted:
01
04
2023
medline:
22
4
2023
pubmed:
22
4
2023
entrez:
21
04
2023
Statut:
aheadofprint
Résumé
Reconstruction of right ventricular outflow tract in patients with congenital heart disease in various age groups remains a controversial issue. Currently, a little is known about the fate of secondary and subsequent conduit. The aim of the study was to determine risk factors of conduit failure, evaluate long-term conduit survival, find out which type of conduit should be preferred in case of reoperations. We performed a retrospective analysis of a total of 249 records of valved conduit secondary and subsequent replacement in right ventricular outflow tract in 197 patients. Median follow-up was 5.7 years. The study endpoints were defined as conduit explants; balloon dilatation of the graft (excluding balloon dilatation of left/right pulmonary artery), transcatheter pulmonary valve implantation; heart transplantation or death of the patient. There were total of 21 deaths (11% mortality) among 197 patients during the follow-up, 2 patients underwent heart transplant, in 23 implanted conduits pulmonary angioplasty or/including transcatheter pulmonary valve implantation was afterwards performed due to graft failure, conduit had to be explanted in 46 cases. After 28 years follow-up, freedom from graft failure after 5 years was 77%, 48% after 10 years and 21% after 15 years. Reoperative right ventricular outflow tract reconstruction demonstrates good mid-term and acceptable long-term outcomes regardless of the type of conduit implanted. Worse long-term graft survival of secondary and further conduits is associated with younger age of the recipient at implantation, small size of the conduit, younger age of donor and male donor in case of allograft implantation.
Identifiants
pubmed: 37085639
doi: 10.1007/s10561-023-10088-y
pii: 10.1007/s10561-023-10088-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Albert JD, Bishop DA, Fullerton DA, Campbell DN, Clarke DR (1993) Conduit reconstruction of the right ventricular outflow tract. Lessons learned in a twelve-year experience. J Thorac Cardiovasc Surg 106(2):228–235 (discussion 235–6)
doi: 10.1016/S0022-5223(19)34120-0
pubmed: 8341063
Baskett RJ, Ross DB, Nanton MA, Murphy DA (1996) Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity? J Thorac Cardiovasc Surg 112(5):1170–1178. https://doi.org/10.1016/S0022-5223(96)70130-7 (discussion 1178–9)
doi: 10.1016/S0022-5223(96)70130-7
pubmed: 8911313
Bielefeld MR, Bishop DA, Campbell DN, Mitchell MB, Grover FL, Clarke DR (2001) Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg. 71(2):482–487. https://doi.org/10.1016/s0003-4975(00)02521-2 (discussion 487–8)
doi: 10.1016/s0003-4975(00)02521-2
pubmed: 11235694
Brown JW (2018) Polytetrafluoroethylene valved conduits for right ventricle-pulmonary artery reconstruction: do they outperform xenografts and allografts? J Thorac Cardiovasc Surg 155(6):2577–2578. https://doi.org/10.1016/j.jtcvs.2018.01.019
doi: 10.1016/j.jtcvs.2018.01.019
pubmed: 29530576
Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW (2005) Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 80(2):655–663. https://doi.org/10.1016/j.athoracsur.2005.02.053 (discussion 663–4)
doi: 10.1016/j.athoracsur.2005.02.053
pubmed: 16039222
Brown JW, Ruzmetov M, Vijay P, Rodefeld MD, Turrentine MW (2007) Right ventricular outflow tract reconstruction with a polytetrafluoroethylene monocusp valve: a twelve-year experience. J Thorac Cardiovasc Surg 133(5):1336–1343. https://doi.org/10.1016/j.jtcvs.2006.12.045
doi: 10.1016/j.jtcvs.2006.12.045
pubmed: 17467453
Burkert J, Krs O, Vojácek J et al (2008) Cryopreserved semilunar heart valve allografts: leaflet surface damage in scanning electron microscopy. Zentralbl Chir 133(4):367–373. https://doi.org/10.1055/s-2008-1076872
doi: 10.1055/s-2008-1076872
pubmed: 18702023
Burkert J, Kochová P, Tonar Z et al (2021) The time has come to extend the expiration limit of cryopreserved allograft heart valves. Cell Tissue Bank 22(2):161–184. https://doi.org/10.1007/s10561-020-09843-2
doi: 10.1007/s10561-020-09843-2
pubmed: 32583302
Cleveland DC, Williams WG, Razzouk AJ et al (1992) Failure of cryopreserved homograft valved conduits in the pulmonary circulation. Circulation 86(5 Suppl):II150–II153
pubmed: 1423992
da Costa FDA, Etnel JRG, Torres R, Balbi Filho EM, Calixto A, Mulinari LA (2017) Decellularized allografts for right ventricular outflow tract reconstruction in children. World J Pediatr Congenit Heart Surg 8(5):605–612. https://doi.org/10.1177/2150135117723916
doi: 10.1177/2150135117723916
pubmed: 28901232
Fiala R, Kochová P, Kubíková T et al (2019) Mechanical and structural properties of human aortic and pulmonary allografts do not deteriorate in the first 10 years of cryopreservation and storage in nitrogen. Cell Tissue Bank 20(2):221–241. https://doi.org/10.1007/s10561-019-09762-x
doi: 10.1007/s10561-019-09762-x
pubmed: 30903411
Hlubocký J, Mokráček A, Nováček V et al (2011) Mechanical properties of mitral allografts are not reasonably influenced by cryopreservation in sheep model. Physiol Res 60(3):475–482. https://doi.org/10.33549/physiolres.932074
doi: 10.33549/physiolres.932074
pubmed: 21401294
Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9(7):811–818. https://doi.org/10.1002/sim.4780090710
doi: 10.1002/sim.4780090710
pubmed: 2218183
Jonas RA, Freed MD, Mayer JE, Castaneda AR (1985) Long-term follow-up of patients with synthetic right heart conduits. Circulation 72(3 Pt 2):II77–II83
pubmed: 3161661
Kalfa D, Macé L, Metras D, Kreitmann B (2011) How to choose the best available homograft to reconstruct the right ventricular outflow tract. J Thorac Cardiovasc Surg 142(4):950–953. https://doi.org/10.1016/j.jtcvs.2011.03.005
doi: 10.1016/j.jtcvs.2011.03.005
pubmed: 21458007
Kalfa DM, Loundou A, Nouaille de Gorce Y et al (2012) Pulmonary position cryopreserved homograft in non-Ross patients: how to improve the results? Eur J Cardiothorac Surg 42(6):981–987. https://doi.org/10.1093/ejcts/ezs248
doi: 10.1093/ejcts/ezs248
pubmed: 22573719
Kassambara A, Kosinski M, Biecek P, Fabian S (2017) survminer: drawing survival curves using ‘ggplot2’. R package version 03
Koirala B, Merklinger SL, Van Arsdell GS et al (2002) Extending the usable size range of homografts in the pulmonary circulation: outcome of bicuspid homografts. Ann Thorac Surg 73(3):866–869. https://doi.org/10.1016/s0003-4975(01)03559-7 (discussion 869–70)
doi: 10.1016/s0003-4975(01)03559-7
pubmed: 11899193
Lewis MJ, Malm T, Hallbergson A et al (2023) Long-term follow-up of right ventricle to pulmonary artery biologic valved conduits used in pediatric congenital heart surgery. Pediatr Cardiol 44(1):102–115. https://doi.org/10.1007/s00246-022-02956-3
doi: 10.1007/s00246-022-02956-3
pubmed: 35780430
Meyns B, Jashari R, Gewillig M et al (2005) Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur J Cardiothorac Surg 28(2):211–216. https://doi.org/10.1016/j.ejcts.2005.03.041 (discussion 216)
doi: 10.1016/j.ejcts.2005.03.041
pubmed: 15953733
Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC (1999) Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg 117(1):141–146. https://doi.org/10.1016/s0022-5223(99)70479-4 (discussion 46–7)
doi: 10.1016/s0022-5223(99)70479-4
pubmed: 9869768
Rodefeld MD, Ruzmetov M, Turrentine MW, Brown JW (2008) Reoperative right ventricular outflow tract conduit reconstruction: risk analyses at follow up. J Heart Valve Dis 17(1):119–126 (discussion 126)
pubmed: 18365579
Ross DN, Somerville J (1966) Correction of pulmonary atresia with a homograft aortic valve. Lancet 2(7479):1446–1447. https://doi.org/10.1016/s0140-6736(66)90600-3
doi: 10.1016/s0140-6736(66)90600-3
pubmed: 4163445
Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M (1998) Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 115(3):506–514. https://doi.org/10.1016/S0022-5223(98)70312-5 (discussion 514–6)
doi: 10.1016/S0022-5223(98)70312-5
pubmed: 9535436
Therneau TM, Grambsch PM (2000) modeling survival data: extending the Cox model. Statistics for biology and health, 1st edn. Springer, New York
doi: 10.1007/978-1-4757-3294-8
Tweddell JS, Pelech AN, Frommelt PC et al (2000) Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 102(19 Suppl 3):III130–III135. https://doi.org/10.1161/01.cir.102.suppl_3.iii-130
doi: 10.1161/01.cir.102.suppl_3.iii-130
pubmed: 11082375
van de Woestijne PC, Mokhles MM, de Jong PL, Witsenburg M, Takkenberg JJ, Bogers AJ (2011) Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up. Ann Thorac Surg 92(1):161–166. https://doi.org/10.1016/j.athoracsur.2011.02.036
doi: 10.1016/j.athoracsur.2011.02.036
pubmed: 21592455
Vogt PR, Stallmach T, Niederhäuser U et al (1999) Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 15(5):639–644. https://doi.org/10.1016/s1010-7940(99)00053-6 (discussion 644–5)
doi: 10.1016/s1010-7940(99)00053-6
pubmed: 10386410
Warrell DA, Cox TM, Firth JD, Dwight J (2016) Oxford textbook of medicine: cardiovascular disorders: selected and updated chapters from the Oxford textbook of medicine, 5th edn. Oxford University Press, Oxford